Federated Hermes’s CytomX Therapeutics CTMX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q3
Sell
-398
Closed -$903 2142
2025
Q2
$903 Buy
+398
New +$642 ﹤0.01% 2008
2024
Q4
Sell
-117
Closed -$138 2100
2024
Q3
$138 Hold
117
﹤0.01% 2019
2024
Q2
$143 Sell
117
-4,271
-97% -$8.5K ﹤0.01% 1990
2024
Q1
$9.57K Buy
4,388
+903
+26% +$1.67K ﹤0.01% 1780
2023
Q4
$5.4K Buy
3,485
+2,070
+146% +$2.72K ﹤0.01% 1843
2023
Q3
$1.82K Hold
1,415
﹤0.01% 1975
2023
Q2
$2.43K Hold
1,415
﹤0.01% 1983
2023
Q1
$2.14K Sell
1,415
-2,127
-60% -$4.81K ﹤0.01% 1999
2022
Q4
$5.67K Sell
3,542
-715
-17% -$1.06K ﹤0.01% 1916
2022
Q3
$6K Buy
4,257
+424
+11% +$652 ﹤0.01% 1873
2022
Q2
$7K Buy
3,833
+3,752
+4,632% +$7.18K ﹤0.01% 1858
2022
Q1
$1K Sell
81
-961,393
-100% -$3.69M ﹤0.01% 2076
2021
Q4
$4.16M Sell
961,474
-123
-0% -$721 0.01% 865
2021
Q3
$4.89M Buy
961,597
+29,590
+3% +$158K 0.01% 830
2021
Q2
$5.9M Buy
932,007
+338,586
+57% +$2.64M 0.01% 796
2021
Q1
$4.59M Buy
593,421
+230,763
+64% +$1.83M 0.01% 881
2020
Q4
$2.38M Buy
362,658
+344,186
+1,863% +$2.46M ﹤0.01% 1000
2020
Q3
$123K Buy
18,472
+11,653
+171% +$86.4K ﹤0.01% 1710
2020
Q2
$57K Buy
+6,819
New +$63.3K ﹤0.01% 1765
2019
Q4
Sell
-6,970
Closed -$51K 2225
2019
Q3
$51K Buy
+6,970
New +$68.8K ﹤0.01% 1723
2018
Q2
Sell
-125,932
Closed -$3.58M 2211
2018
Q1
$3.58M Buy
125,932
+56,582
+82% +$1.61M 0.01% 741
2017
Q4
$1.46M Buy
+69,350
New +$1.44M ﹤0.01% 1068

Other funds holding CTMX